| Calyxt is a technology company focused on delivering plant-based solutions. Co. is engaged in gene editing with access to proprietary TALEN® and other technologies for use in plants. Co. is exploring projects in addressable markets including oats, hemp, and soybeans. Using its proprietary technologies, including TALEN gene editing technology licensed to it in the field of agriculture, Co. develops crops with targeted traits. Co.'s technologies enable precise cuts to DNA in a single plant cell, and then the plant's natural repair mechanism occurs resulting in the edited plant. Co. then regenerate the edited single cell into a full plant. We show 20 historical shares outstanding datapoints in our coverage of CLXT's shares outstanding history.|
Understanding the changing numbers of CLXT shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like CLXT versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching CLXT by allowing them to research CLXT shares outstanding history
as well as any other stock in our coverage universe.